Dutch medical technology company Philips said on Thursday that it is revising down a key profit indicator this year because of ‘increasing headwinds from tariffs’.
The company now expects its Ebita margin – operating profit as a percentage of turnover – to rise by no more than 0.2% this year.
For the past three years Philips has hit its target of a 1% increase and that had been the target for 2019.
But now the trade war and high import tariffs have hit performance at the company’s ‘connected care’ division, which makes sleep aids and breathing apparatus, among others.
The company expects net income from continuing operations will amount to approximately €210m in the quarter, which will include a charge of €78m related to a goodwill impairment in the connected care unit.
‘We will drive further strong mitigating actions to accelerate the improvement in these businesses,’ chief executive Frank van Houten said in a press statement.
The firm has maintained its target of improving comparable sales by between 4% and 6% next year.
The finalised figures will be published on October 28.
Thank you for donating to DutchNews.nl
The DutchNews.nl team would like to thank all the generous readers who have made a donation in recent weeks. Your financial support has helped us to expand our coverage of the coronavirus crisis into the evenings and weekends and make sure you are kept up to date with the latest developments.
DutchNews.nl has been free for 14 years, but without the financial backing of our readers, we would not be able to provide you with fair and accurate news and features about all things Dutch. Your contributions make this possible.